CA Patent

CA2744563A1 — Azaindole derivatives as kinase inhibitors

Assigned to Ariad Pharmaceuticals Inc · Expires 2010-06-17 · 16y expired

What this patent protects

This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

USPTO Abstract

This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

Drugs covered by this patent

Patent Metadata

Patent number
CA2744563A1
Jurisdiction
CA
Classification
—
Expires
2010-06-17
Drug substance claim
No
Drug product claim
No
Assignee
Ariad Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.